Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2015
USD ($)
|
Jun. 30, 2014
USD ($)
|
Mar. 31, 2014 |
Jun. 30, 2015
USD ($)
shares
|
Jun. 30, 2014
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) [Line Items] | ||||||
Cash Equivalents, at Carrying Value | $ 163,670 | $ 163,670 | $ 491,988 | |||
Purchase Commitment, Description | The terms for the purchase of the product require 50% prepayment at the time of order, and the remaining 50% is paid prior to shipment to the United States. In addition to the prepayment terms, the supplier also provides the Company with a 2% overallotment of units to replace any fallout during incoming receiving inspection. The Company recognized the total number of units received and in stock at the end of the period, and allows for a 2% scrap allowance to offset any potential losses incurred. | |||||
Inventory Valuation Reserves | 59,510 | 59,510 | ||||
Allowance for Doubtful Accounts Receivable, Current | 478 | 478 | 4,978 | |||
Revenues | 47,427 | $ 13,967 | $ 95,308 | $ 19,012 | ||
Standard Product Warranty Description | offers a 90-day limited warranty on its core product with an opportunity to upgrade to a one year limited warranty (for a fee) on the device | |||||
Deferred Revenue, Current | 11,481 | $ 11,481 | $ 4,513 | |||
Product Warranty Expense | 3,483 | 955 | ||||
Research and Development Expense | $ 94,353 | $ 107,248 | ||||
Warrant [Member] | ||||||
Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) [Line Items] | ||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) | shares | 23,485,923 | |||||
Convertible Debt Securities [Member] | ||||||
Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) [Line Items] | ||||||
Convertible Debt | $ 7,182,500 | $ 7,182,500 | ||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares | 95,766,667 | |||||
ProV2 [Member] | ||||||
Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) [Line Items] | ||||||
Inventory, Number of Units | 1,396 | 10,600 | ||||
ProV2 [Member] | Initial Purchase Order [Member] | ||||||
Note 1 - Company Organization and Summary of Significant Accounting Policies (Details) [Line Items] | ||||||
Inventory, Number of Units | 11,800 |
X | ||||||||||
- Definition Number of units of inventory. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of valuation reserve for inventory. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Excluding long-term commitments, description of arrangements in which the entity has agreed to expend funds to procure goods or services from one or more suppliers, which may include identification of the goods or services to be purchased, identity of the seller, pricing, effects on pricing (such as penalties) of failing to reach minimum quantities required to be purchased, cancellation rights, and termination provisions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|